Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHS
Pelthos Therapeutics Inc.US flagNew York Stock Exchange American
25.88
USD
-0.12
- -
16.78MMarket Cap

Pelthos Therapeutics Inc. (PTHS) Stock Splits

Learn about Pelthos Therapeutics Inc.'s most recent 1-for-10 basis stock split on July 02, 2025. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Pelthos Therapeutics Inc.'s most recent stock split

Split Date: 2025-07-02
Split Ratio: 1:10
Price Before Split: $1.65
Price After Split: $0.17

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Pelthos Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-07-021:10Yes$1.65$0.17

About Pelthos Therapeutics Inc.

Company overview and industry information

Pelthos Therapeutics Inc. (PTHS) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Pelthos Therapeutics Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.

PTHS Stock Splits — Pelthos Therapeutics Inc. | Roic AI